You have 9 free searches left this month | to do more

cyclophosphamide

Cyclophosphamide is a drug used to treat Lymphoma, Breast Cancer, Leukemia, and other conditions. Cyclophosphamide is being actively studied in 730 studies and prior, has been studied in 1084.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Roswell Park Cancer InstituteSteven Rosenberg, M.D.
M.D. Anderson Cancer CenterWashington University School of MedicineRichard Burt, MD
Children's Oncology GroupUniversity of Texas Health Science Center at San AntonioRobert Krance
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Active, not recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Duarte, California
  • +1 more
2022-03-17
Mar 17, 2022
I
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
Recruiting
  • Solid Tumors
  • +2 more
  • Cyclophosphamide and JX-594 dose escalation
  • +3 more
  • Bordeaux, France
    Institut Bergonie
2022-02-01
Feb 1, 2022
S
High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Withdrawn
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Cyclophosphamide
  • (no location specified)
2021-11-02
Nov 2, 2021
U
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
Recruiting
  • Metastatic Thyroid Cancer
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
2021-12-15
Dec 15, 2021
M
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab - 2022
Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-03-03
Mar 3, 2022
C
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes
Recruiting
  • Lipodystrophy Acquired
  • Type1diabetes
  • Cyclophosphamide
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
2021-10-21
Oct 21, 2021
A
Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
Suspended
  • Leukemia, Not Otherwise Specified
  • Leukemia, Other
  • Cyclophosphamide
  • Specimen collection
  • Charlotte, North Carolina
    Levine Cancer Institute
2022-02-15
Feb 15, 2022
S
Compare the Efficacy and the Safety of Doxorubicin and Cyclophosphamide Followed by Taxotere Versus Doxorubicin and Cyclophosphamide Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer
Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
2022-01-20
Jan 20, 2022
N
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
2022-04-04
Apr 4, 2022
E
Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients
Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
2022-03-24
Mar 24, 2022
E
Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)
Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
2022-03-24
Mar 24, 2022
H
Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS) - 2019
Completed
  • Chronic Fatigue Syndrome (CFS)
  • Myalgic Encephalomyelitis (ME)
  • Cyclophosphamide
  • Bergen, Norway
    Dept. of Oncology, Haukeland University Hospital
2021-05-10
May 10, 2021
N
Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Active, not recruiting
Has Results
  • Adult T-Cell Leukemia (ATL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-13
Jan 13, 2022
U
Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia - 2021
Completed
  • Acute Myeloid Leukemia
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Cyclophosphamide
  • Aurora, Colorado
    University of Colorado Denver
2021-04-28
Apr 28, 2021
U
Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients - 2018
Withdrawn
  • Radiotherapy
  • Immunology
  • Cyclophosphamide
  • Stereotactic body radiotherapy
  • Ghent, Belgium
    University Hospital - Radiotherapy Department
2021-07-07
Jul 7, 2021
U
Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients
Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
2021-09-27
Sep 27, 2021
U
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis
Active, not recruiting
  • Leukemia
  • +5 more
  • Cyclophosphamide
  • Birmingham, Alabama
    UAB Bone Marrow Transplantation and Cellular Therapy Program
2021-06-24
Jun 24, 2021
N
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia - 2012
Completed
Has Results
  • Aplastic Anemia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-06-07
Jun 7, 2021
D
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy
Recruiting
  • GVHD
  • Hematologic Neoplasms
  • Cyclophosphamide
  • +3 more
  • La Jolla, California
    UC San Diego Moores Cancer Center
2022-03-21
Mar 21, 2022
N
High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
Recruiting
  • Chronic Granulomatous Disease Transplant
  • Alentuzumab (Campath)
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
C
TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis
Recruiting
  • Systemic Scleroderma
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
    City of Hope Medical Center
2022-03-07
Mar 7, 2022
N
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
Recruiting
  • Hematologic Neoplasms
  • Mycophenolate Mofetil
  • +7 more
  • Bethesda, Maryland
  • +1 more
2022-04-07
Apr 7, 2022
N
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
Suspended
  • Chronic Granulomatous Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
M
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients
Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +1 more
2022-03-14
Mar 14, 2022
U
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Recruiting
  • Advanced Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-11-29
Nov 29, 2021